1. Afatinib versus cisplatin-based chemotherapy for EGFR mutation-positive lung adenocarcinoma (LUX-Lung 3 and LUX-Lung 6): analysis of overall survival data from two randomised, phase 3 trials. Issue 2 (February 2015) Authors: Yang, James Chih-Hsin; Wu, Yi-Long; Schuler, Martin; Sebastian, Martin; Popat, Sanjay; Yamamoto, Nobuyuki; Zhou, Caicun; Hu, Cheng-Ping; O'Byrne, Kenneth; Feng, Jifeng; Lu, Shun; Huang, Yunchao; Geater, Sarayut L; Lee, Kye Young; Tsai, Chun-Ming; Gorbunova, Vera; Hirsh, Vera; Bennouna, Jaafar; Or... Journal: Lancet oncology Issue: Volume 16:Issue 2(2015:Feb.) Page Start: 141 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Afatinib versus cisplatin-based chemotherapy for EGFR mutation-positive lung adenocarcinoma (LUX-Lung 3 and LUX-Lung 6): analysis of overall survival data from two randomised, phase 3 trials. Issue 2 (February 2015) Authors: Yang, James Chih-Hsin; Wu, Yi-Long; Schuler, Martin; Sebastian, Martin; Popat, Sanjay; Yamamoto, Nobuyuki; Zhou, Caicun; Hu, Cheng-Ping; O'Byrne, Kenneth; Feng, Jifeng; Lu, Shun; Huang, Yunchao; Geater, Sarayut L; Lee, Kye Young; Tsai, Chun-Ming; Gorbunova, Vera; Hirsh, Vera; Bennouna, Jaafar; Or... Journal: Lancet oncology Issue: Volume 16:Issue 2(2015:Feb.) Page Start: 141 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Afatinib versus gefitinib as first-line treatment of patients with EGFR mutation-positive non-small-cell lung cancer (LUX-Lung 7): a phase 2B, open-label, randomised controlled trial. Issue 5 (May 2016) Authors: Park, Keunchil; Tan, Eng-Huat; O'Byrne, Ken; Zhang, Li; Boyer, Michael; Mok, Tony; Hirsh, Vera; Yang, James Chih-Hsin; Lee, Ki Hyeong; Lu, Shun; Shi, Yuankai; Kim, Sang-We; Laskin, Janessa; Kim, Dong-Wan; Arvis, Catherine Dubos; Kölbeck, Karl; Laurie, Scott A; Tsai, Chun-Ming; Shahidi, Mehdi; Kim... Journal: Lancet oncology Issue: Volume 17:Issue 5(2016:May) Page Start: 577 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Association Between Serum Folate Level and Toxicity of Capecitabine During Treatment for Colorectal Cancer. (25th May 2018) Authors: Chan, Stephen L.; Chan, Anthony W.H.; Mo, Frankie; Ma, Brigette B.Y.; Wong, Kenneth C.W.; Lam, Daisy; Mok, Florence S.T.; Chan, Anthony T.C.; Mok, Tony; Chan, K.C. Allen Journal: Oncologist Issue: Volume 23:Number 12(2018) Page Start: 1436 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Ceritinib versus chemotherapy in patients with ALK-rearranged non-small-cell lung cancer previously given chemotherapy and crizotinib (ASCEND-5): a randomised, controlled, open-label, phase 3 trial. Issue 7 (July 2017) Authors: Shaw, Alice T; Kim, Tae Min; Crinò, Lucio; Gridelli, Cesare; Kiura, Katsuyuki; Liu, Geoffrey; Novello, Silvia; Bearz, Alessandra; Gautschi, Oliver; Mok, Tony; Nishio, Makoto; Scagliotti, Giorgio; Spigel, David R; Deudon, Stéphanie; Zheng, Cheng; Pantano, Serafino; Urban, Patrick; Massacesi, Crist... Journal: Lancet oncology Issue: Volume 18:Issue 7(2017:Jul.) Page Start: 874 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Challenges and opportunities of cfDNA analysis implementation in clinical practice: Perspective of the International Society of Liquid Biopsy (ISLB). (July 2020) Authors: Rolfo, Christian; Cardona, Andrés F.; Cristofanilli, Massimo; Paz-Ares, Luis; Diaz Mochon, Juan Jose; Duran, Ignacio; Raez, Luis E.; Russo, Alessandro; Lorente, Jose A.; Malapelle, Umberto; Gil-Bazo, Ignacio; Jantus-Lewintre, Eloisa; Pauwels, Patrick; Mok, Tony; Serrano, María José Journal: Critical reviews in oncology/hematology Issue: Volume 151(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Clinical utility of a blood-based EGFR mutation test in patients receiving first-line erlotinib therapy in the ENSURE, FASTACT-2, and ASPIRATION studies. (December 2018) Authors: Wu, Yi-Long; Lee, Victor; Liam, Chong-Kin; Lu, Shun; Park, Keunchil; Srimuninnimit, Vichien; Wang, Jie; Zhou, Caicun; Appius, Anita; Button, Peter; Hooper, Gregory; Palma, John F.; Schulze, Katja; Scudder, Sidney; Shames, David S.; Yin, Anny-Yue; Zhang, Guili; Mok, Tony Journal: Lung cancer Issue: Volume 126(2018) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Corrigendum to "Challenges and opportunities of cfDNA analysis implementation in clinical practice: Perspective of the International Society of Liquid Biopsy (ISLB)" [Crit. Rev. Oncol. Hematol. 151 (July) (2020) 102978]. (October 2020) Authors: Rolfo, Christian; Cardona, Andrés F.; Cristofanilli, Massimo; Paz-Ares, Luis; Diaz Mochon, Juan Jose; Duran, Ignacio; Raez, Luis E.; Russo, Alessandro; Lorente, Jose A.; Malapelle, Umberto; Gil-Bazo, Ignacio; Jantus-Lewintre, Eloisa; Pauwels, Patrick; Mok, Tony; Serrano, María José Journal: Critical reviews in oncology/hematology Issue: Volume 154(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Dacomitinib for the treatment of advanced or metastatic non-small-cell lung cancer. (April 2014) Authors: Mok, Tony; Lee, Kirsty; Tang, Michael; Leung, Linda Journal: Future oncology Issue: Volume 10:Number 5(2014) Page Start: 813 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Durvalumab With or Without Tremelimumab in Combination With Chemotherapy as First-Line Therapy for Metastatic Non–Small-Cell Lung Cancer: The Phase III POSEIDON Study. Issue 6 (20th February 2023) Authors: Johnson, Melissa L.; Cho, Byoung Chul; Luft, Alexander; Alatorre-Alexander, Jorge; Geater, Sarayut Lucien; Laktionov, Konstantin; Kim, Sang-We; Ursol, Grygorii; Hussein, Maen; Lim, Farah Louise; Yang, Cheng-Ta; Araujo, Luiz Henrique; Saito, Haruhiro; Reinmuth, Niels; Shi, Xiaojin; Poole, Lynne; P... Journal: Journal of clinical oncology Issue: Volume 41:Issue 6(2023) Page Start: 1213 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗